Inhibition of Notch signaling attenuates pituitary adenoma growth in Nude mice. Issue 1 (January 2019)
- Record Type:
- Journal Article
- Title:
- Inhibition of Notch signaling attenuates pituitary adenoma growth in Nude mice. Issue 1 (January 2019)
- Main Title:
- Inhibition of Notch signaling attenuates pituitary adenoma growth in Nude mice
- Authors:
- Zubeldía-Brenner, Lautaro
De Winne, Catalina
Perrone, Sofía
Rodríguez-Seguí, Santiago A
Willems, Christophe
Ornstein, Ana María
Lacau-Mengido, Isabel
Vankelecom, Hugo
Cristina, Carolina
Becu-Villalobos, Damasia - Abstract:
- Abstract : Preclinical and clinical studies support that Notch signaling may play an important oncogenic role in cancer, but there is scarce information for pituitary tumors. We therefore undertook a functional study to evaluate Notch participation in pituitary adenoma growth. Tumors generated in Nude mice by subcutaneous GH3 somatolactotrope cell injection were treated in vivo with DAPT, a γ-secretase inhibitor, thus inactivating Notch signaling. This treatment led to pituitary tumor reduction, lower prolactin and GH tumor content and a decrease in angiogenesis. Furthermore, in silico transcriptomic and epigenomic analyses uncovered several tumor suppressor genes related to Notch signaling in pituitary tissue, namely Btg2, Nr4a1, Men1, Zfp36 and Cnot1. Gene evaluation suggested that Btg2, Nr4a1 and Cnot1 may be possible players in GH3 xenograft growth. Btg2 mRNA expression was lower in GH3 tumors compared to the parental line, and DAPT increased its expression levels in the tumor in parallel with the inhibition of its volume. Cnot1 mRNA levels were also increased in the pituitary xenografts by DAPT treatment. And the Nr4a1 gene was lower in tumors compared to the parental line, though not modified by DAPT. Finally, because DAPT in vivo may also be acting on tumor microenvironment, we determined the direct effect of DAPT on GH3 cells in vitro . We found that DAPT decreases the proliferative, secretory and migration potential of GH3 cells. These results position selectiveAbstract : Preclinical and clinical studies support that Notch signaling may play an important oncogenic role in cancer, but there is scarce information for pituitary tumors. We therefore undertook a functional study to evaluate Notch participation in pituitary adenoma growth. Tumors generated in Nude mice by subcutaneous GH3 somatolactotrope cell injection were treated in vivo with DAPT, a γ-secretase inhibitor, thus inactivating Notch signaling. This treatment led to pituitary tumor reduction, lower prolactin and GH tumor content and a decrease in angiogenesis. Furthermore, in silico transcriptomic and epigenomic analyses uncovered several tumor suppressor genes related to Notch signaling in pituitary tissue, namely Btg2, Nr4a1, Men1, Zfp36 and Cnot1. Gene evaluation suggested that Btg2, Nr4a1 and Cnot1 may be possible players in GH3 xenograft growth. Btg2 mRNA expression was lower in GH3 tumors compared to the parental line, and DAPT increased its expression levels in the tumor in parallel with the inhibition of its volume. Cnot1 mRNA levels were also increased in the pituitary xenografts by DAPT treatment. And the Nr4a1 gene was lower in tumors compared to the parental line, though not modified by DAPT. Finally, because DAPT in vivo may also be acting on tumor microenvironment, we determined the direct effect of DAPT on GH3 cells in vitro . We found that DAPT decreases the proliferative, secretory and migration potential of GH3 cells. These results position selective interruption of Notch signaling as a potential therapeutic tool in adjuvant treatments for aggressive or resistant pituitary tumors. … (more)
- Is Part Of:
- Endocrine-related cancer. Volume 26:Issue 1(2019)
- Journal:
- Endocrine-related cancer
- Issue:
- Volume 26:Issue 1(2019)
- Issue Display:
- Volume 26, Issue 1 (2019)
- Year:
- 2019
- Volume:
- 26
- Issue:
- 1
- Issue Sort Value:
- 2019-0026-0001-0000
- Page Start:
- 13
- Page End:
- 29
- Publication Date:
- 2019-01
- Subjects:
- DAPT -- pituitary -- angiogenesis -- prolactin -- GH
Endocrine glands -- Cancer -- Periodicals
Endocrinology -- Periodicals
Cancer -- Endocrine aspects -- Periodicals
616.9944005 - Journal URLs:
- http://www.bioscientifica.com/ ↗
http://erc.endocrinology-journals.org/ ↗ - DOI:
- 10.1530/ERC-18-0337 ↗
- Languages:
- English
- ISSNs:
- 1351-0088
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 15453.xml